CG ONCOLOGY INC
(NASDAQ: CGON)
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul DeRidder on September 24, 2010 and is headquartered in Irvine, CA.
27.350
+1.510
(+5.84%)
Range
26.910 - 29.500
(9.62%)
Open
-
Previous Close
25.840
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
1,448,007
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis